Cubist Systematic Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-293,675
Closed -$893K 2443
2024
Q4
$893K Buy
293,675
+63,066
+27% +$192K 0.01% 838
2024
Q3
$1.2M Buy
+230,609
New +$1.2M 0.01% 760
2024
Q2
Sell
-35,521
Closed -$175K 2788
2024
Q1
$175K Sell
35,521
-269,926
-88% -$1.33M ﹤0.01% 1712
2023
Q4
$2.68M Buy
305,447
+85,234
+39% +$749K 0.02% 693
2023
Q3
$2.53M Sell
220,213
-40,594
-16% -$466K 0.02% 697
2023
Q2
$6.6M Buy
260,807
+87,121
+50% +$2.21M 0.04% 399
2023
Q1
$5.59M Sell
173,686
-109,141
-39% -$3.52M 0.03% 538
2022
Q4
$5.22M Buy
282,827
+176,199
+165% +$3.25M 0.03% 658
2022
Q3
$2.88M Sell
106,628
-138,584
-57% -$3.74M 0.02% 1284
2022
Q2
$3.39M Buy
245,212
+221,707
+943% +$3.06M 0.02% 1119
2022
Q1
$458K Sell
23,505
-32,001
-58% -$624K ﹤0.01% 2567
2021
Q4
$906K Buy
55,506
+35,608
+179% +$581K 0.01% 1987
2021
Q3
$554K Sell
19,898
-14,800
-43% -$412K 0.01% 1962
2021
Q2
$1.03M Buy
34,698
+27,008
+351% +$800K 0.01% 1554
2021
Q1
$215K Buy
+7,690
New +$215K ﹤0.01% 2423
2020
Q4
Sell
-34,052
Closed -$856K 2744
2020
Q3
$856K Buy
+34,052
New +$856K 0.01% 1428
2020
Q2
Sell
-108,435
Closed -$1.61M 2554
2020
Q1
$1.61M Buy
108,435
+62,350
+135% +$923K 0.04% 569
2019
Q4
$748K Buy
+46,085
New +$748K 0.01% 1336
2019
Q3
Sell
-35,982
Closed -$467K 2538
2019
Q2
$467K Buy
35,982
+471
+1% +$6.11K 0.01% 1521
2019
Q1
$560K Buy
+35,511
New +$560K 0.02% 1115
2018
Q3
Sell
-8,795
Closed -$241K 2106
2018
Q2
$241K Buy
8,795
+2,654
+43% +$72.7K 0.01% 1223
2018
Q1
$189K Buy
+6,141
New +$189K 0.01% 1427